We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Nivolumab and Temozolomide Versus Temozolomide Alone in Newly Diagnosed Elderly Patients With GBM (NUTMEG)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04195139
Recruitment Status : Active, not recruiting
First Posted : December 11, 2019
Last Update Posted : July 19, 2022
Sponsor:
Collaborator:
Cooperative Trials Group for Neuro-Oncology
Information provided by (Responsible Party):
University of Sydney

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : December 31, 2023
Estimated Study Completion Date : December 31, 2024